JANE STREET GROUP, LLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2022$32,000
+6.7%
20,461
+69.1%
0.00%
Q1 2022$30,000
-88.7%
12,100
-72.7%
0.00%
Q4 2021$266,000
-66.5%
44,295
-62.8%
0.00%
Q3 2021$794,000
+50.4%
119,200
+50.1%
0.00%
Q2 2021$528,000
-46.6%
79,400
-25.6%
0.00%
Q1 2021$988,000
-43.5%
106,657
+9.6%
0.00%
-100.0%
Q4 2020$1,750,000
+1.4%
97,300
-20.0%
0.00%0.0%
Q3 2020$1,725,000121,6000.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$299,0000.32%
Artal Group S.A. 750,000$1,860,0000.08%
Eventide Asset Management 1,467,922$3,640,0000.06%
Atom Investors LP 33,798$84,0000.04%
XTX Topco Ltd 25,154$62,0000.03%
ELKHORN PARTNERS LIMITED PARTNERSHIP 19,000$47,0000.02%
Engineers Gate Manager LP 245,567$609,0000.02%
GSA CAPITAL PARTNERS LLP 63,749$158,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 168,902$419,0000.01%
Walleye Capital LLC 123,305$306,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders